“…To note, a significant portion of these top-ranked top signatures we identified were already found to be involved in glioma signaling in various biological pathways or mechanisms. For example, of top 20 gene expression signatures, more than half have been reported to be involved in gliomas, including BCAN, DLL3, SOX8, SPRY4, MARCKS, EDC3, MCUB, OLIG1, DKK3, ATP1A1, TUBA1B, PPFIBP1, TPM3, and MAPT [43] , [44] , [45] , [46] , [47] , [48] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] . For a comprehensive ranking of landmark omics signatures in patient classification, please refer to Supplemental Table S6 .…”